Richard Malabre
Comptroller/Controller/Auditor chez AKEBIA THERAPEUTICS, INC.
Fortune : 250 824 $ au 31/05/2024
Postes actifs de Richard Malabre
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 08/01/2024 | - |
Historique de carrière de Richard Malabre
Anciens postes connus de Richard Malabre
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Ultivue, Inc.
 Ultivue, Inc. BiotechnologyHealth Technology Ultivue, Inc. engages in provision of biotechnology services. It offers super-resolution imaging, single-molecule and diagnostics services. Its product Multiplex IHC Reagent Kits, a performance marker multiplexing detection and analysis.The company was founded by Peng Yin, David Walt and Ralf Jumgmann in 2015 and is headquartered in Cambridge, MA. | Directeur Financier/CFO | 01/03/2021 | 01/09/2023 |
| Treasurer | 01/03/2021 | 01/09/2023 |
Formation de Richard Malabre
| Massachusetts Institute of Technology | Graduate Degree |
| Trinity College (Connecticut) | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Comptroller/Controller/Auditor | 1 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Finance | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Ultivue, Inc.
Ultivue, Inc. BiotechnologyHealth Technology Ultivue, Inc. engages in provision of biotechnology services. It offers super-resolution imaging, single-molecule and diagnostics services. Its product Multiplex IHC Reagent Kits, a performance marker multiplexing detection and analysis.The company was founded by Peng Yin, David Walt and Ralf Jumgmann in 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Richard Malabre
- Expérience
